2025. Impact of Infections in Patients with Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax during Induction Chemotherapy. Indus Journal of Bioscience Research. 3, 1 (Jan. 2025), 190–196. DOI:https://doi.org/10.70749/ijbr.v3i1.469.